Lanean...
Ubiquitin–proteasome system-targeted therapy for uveal melanoma: what is the evidence?
Uveal melanoma (UM) is a rare ocular tumor. The loss of BRCA1-associated protein 1 (BAP1) and the aberrant activation of G protein subunit alpha q (GNAQ)/G protein subunit alpha 11 (GNA11) contribute to the frequent metastasis of UM. Thus far, limited molecular-targeted therapies have been developed...
Gorde:
| Argitaratua izan da: | Acta Pharmacol Sin |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Singapore
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8027653/ https://ncbi.nlm.nih.gov/pubmed/32601365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-020-0441-3 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|